| Nov 17 |
Analysts Expect Breakeven For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Before Long
|
| Nov 11 |
Sapiens International Posts Downbeat Results, Joins Sky Harbour And Other Big Stocks Moving Lower In Monday's Pre-Market Session
|
| Nov 9 |
Xeris Biopharma Holdings Inc (XERS) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...
|
| Nov 8 |
Xeris Biopharma Holdings, Inc. (XERS) Q3 2024 Earnings Call Transcript
|
| Nov 8 |
Xeris Biopharma (XERS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
|
| Nov 8 |
Xeris Biopharma (XERS) Reports Q3 Loss, Tops Revenue Estimates
|
| Nov 8 |
Xeris Pharmaceuticals GAAP EPS of -$0.11 misses by $0.02, revenue of $54.3M beats by $2.87M
|
| Nov 8 |
Xeris Biopharma: Q3 Earnings Snapshot
|
| Nov 8 |
Xeris Biopharma Reports Third Quarter 2024 Financial Results
|
| Nov 7 |
Xeris Pharmaceuticals Q3 2024 Earnings Preview
|
